Back to today’s briefing

Story perspectives

Direct-to-Patient Platforms Surge Amid Growing Industry Concerns

12/3/2025

29 2 Full Breakdown

Summary

Story summary

Direct-to-patient platforms are expanding rapidly in the U.S. to meet demand for convenience and transparency.
Major pharmaceutical companies have launched DTP initiatives offering integrated services that could alter care pathways.
The lack of shared standards and governance risks fragmentation and shifts incentives away from patient needs.
Inconsistent DTP practices may disadvantage smaller manufacturers and confuse patients about pricing.

1 of 1

Story summary

Direct-to-patient platforms are expanding rapidly in the U.S. to meet demand for convenience and transparency.
Major pharmaceutical companies have launched DTP initiatives offering integrated services that could alter care pathways.
The lack of shared standards and governance risks fragmentation and shifts incentives away from patient needs.
Inconsistent DTP practices may disadvantage smaller manufacturers and confuse patients about pricing.